Literature DB >> 9803141

Bronchiolitis obliterans organising pneumonia secondary to amiodarone treatment.

E Antón Aranda1, R Alkiza Basañez, Y Laplaza Jiménez.   

Abstract

One of the most serious side effects of amiodarone (an antiarrhythmic drug) is pulmonary toxicity. Bronchiolitis obliterans organising pneumonia has only very rarely been described as associated with treatment with amiodarone. In this article we describe a case of bronchiolitis obliterans organising pneumonia secondary to amiodarone.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9803141     DOI： 10.1016/s0300-2977(98)00060-6

Source DB:  PubMed          Journal:  Neth J Med        ISSN： 0300-2977            Impact factor:   1.422


  3 in total

Review 1.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

2.  [Amiodarone-induced pneumonitis. Lethal complication in a patient after thoracic surgery].

Authors:  V Ghezel-Ahmadi; V C Kürschner; A Fisseler-Eckhoff; J Schirren; J E Schmitz; T Obenhaus
Journal:  Anaesthesist       Date:  2008-10       Impact factor: 1.041

3.  A nontrivial differential diagnosis in COVID-19 pandemic: a case report and literary review of amiodarone induced interstitial pneumonia.

Authors:  Luigi Cappannoli; Alessandro Telesca; Roberto Scacciavillani; Edoardo Petrolati; Andrea Smargiassi; Alessia Rabini; Massimo Massetti; Filippo Crea; Nadia Aspromonte
Journal:  Future Cardiol       Date:  2020-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.